KARACHI: Pfizer Pakistan today announced that it will be sponsoring four lung health screening clinics, to support the expansion of Indus Hospital & Health Network’s (IHHN) existing Obstructive Lung Diseases (OLD) program. Under its commitment, Pfizer will be funding the functioning of four IHHN lung health screening clinics in Badin and Tharparkar in Sindh and Rahim Yar Khan (Bhong) and Lahore in Punjab. IHHN’s OLD program is intended to work towards a sole purpose of actively screening all patients for OLD, ensuring early and accurate diagnosis.
“Our aim is to support IHHN’s efforts to identify early signs of obstructive lung disease, which is a respiratory disease characterized by airway obstruction. The funds provided by us will be utilized towards purchase and maintenance of critical equipment and supporting salaries of technicians,” said Syed Muhammad Wajeehuddin, Country Manager Pfizer Pakistan. “This is a collaboration between two reputable organizations that have always kept the interest of their patients and quality paramount. We have complete confidence that these clinics will be instrumental in ensuring a healthy and happy Pakistan. Partnerships like these support our purpose: Breakthroughs that Change Patients’ Lives.”
“One of the biggest challenges in addressing chronic lung disease, such as asthma and Chronic Obstructive Pulmonary Disease, or COPD, in Pakistan is accurate diagnosis,” said Dr. Saima Saeed, Director, Lung Health Program, IHHN. “We are grateful to Pfizer for their donation, which allows access to spirometry within primary care; this is rare in Pakistan. It will reduce the burden of this much neglected non-communicable disease by enabling life-saving interventions to be made sooner and so make a huge impact.”
About Pfizer: Breakthroughs That Change Patients’ Lives Pfizer has been working for the health and wellbeing of patients in Pakistan for more than 60 years. Our business in Pakistan is part of the global Pfizer Inc. operations, first founded in 1849 in New York, USA. Pfizer Pakistan’s reach for patients is 20 million of 200 million.
At Pfizer Pakistan, we provide access to safe, innovative and affordable medicines to millions of Pakistanis. Having a portfolio of medicines that prevent, treat and cure diseases across a range of therapeutic areas allows Pfizer Pakistan to enjoy the reputation of being a leading drug maker in the country.
Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, Pfizer has worked to make a difference for all who rely on us. To learn more about our operations in Pakistan, please visit us at www.pfizer.com.pk.
The post Pfizer Pakistan announces to sponsor four lung health screening clinics appeared first on The Frontier Post.